TEVA PHARMACEUTICAL INDUSTRIES LIMITED OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax of $64.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-12.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax · last filed 2018-02-12
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2017-12-31 was $8.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2017-09-30 was -$20.00M, a 127.03% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2017-06-30 was -$14.00M, a 108.59% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for the quarter ending 2017-03-31 was $90.00M, a 55.22% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2017 was $64.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2016 was -$456.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED oci, debt securities, available-for-sale, gain (loss), before adjustment and tax for fiscal 2015 was -$413.00M.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 3 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 6 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 9 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax 12 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $8.00M derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | -$12.00M derived: sum of 2 quarters · filed 2018-02-12 | -$26.00M derived: sum of 3 quarters · filed 2018-02-12 | $64.00M 10-K · filed 2018-02-12 | |||
| 2017-09-30 | -$20.00M derived: 6-K 9 month − 6-K 6 month · filed 2017-11-02 | -$34.00M derived: sum of 2 quarters · filed 2017-11-02 | $56.00M 6-K · filed 2017-11-02 | $38.00M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2017-06-30 | -$14.00M derived: 6-K 6 month − 6-K 3 month · filed 2017-08-03 | $76.00M 6-K · filed 2017-08-03 | $58.00M derived: sum of 3 quarters · filed 2018-02-12 | $132.00M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2017-03-31 | $90.00M 6-K · filed 2017-05-11 | $72.00M derived: sum of 2 quarters · filed 2018-02-12 | $146.00M derived: sum of 3 quarters · filed 2018-02-12 | $309.00M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2016-12-31 | -$18.00M derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | $56.00M derived: sum of 2 quarters · filed 2018-02-12 | $219.00M derived: sum of 3 quarters · filed 2018-02-12 | -$456.00M 10-K · filed 2018-02-12 | |||
| 2016-09-30 | $74.00M 6-K · filed 2016-11-15 | $237.00M derived: sum of 2 quarters · filed 2016-11-15 | -$438.00M 6-K · filed 2017-11-02 | $438.00M 6-K · filed 2016-11-15 | -$712.00M derived: sum of 4 quarters · filed 2018-02-12 | ||
| 2016-06-30 | $163.00M 6-K · filed 2016-08-04 | -$364.00M 6-K · filed 2017-08-03 | $364.00M 6-K · filed 2016-08-04 | -$786.00M derived: sum of 3 quarters · filed 2018-02-12 | -$122.00M derived: sum of 4 quarters · filed 2018-02-12 | ||
| 2016-03-31 | $201.00M 6-K · filed 2016-05-09 | -$949.00M derived: sum of 2 quarters · filed 2018-02-12 | -$285.00M derived: sum of 3 quarters · filed 2018-02-12 | -$202.00M derived: sum of 4 quarters · filed 2018-02-12 | |||
| 2015-12-31 | -$1.15B derived: 10-K 12 month − 6-K 9 month · filed 2018-02-12 | -$486.00M derived: sum of 2 quarters · filed 2018-02-12 | -$403.00M derived: sum of 3 quarters · filed 2018-02-12 | -$413.00M 10-K · filed 2018-02-12 | |||
| 2015-09-30 | $664.00M 6-K · filed 2016-11-15 | -$664.00M 6-K · filed 2015-10-29 | $747.00M derived: sum of 2 quarters · filed 2016-11-15 | $737.00M 6-K · filed 2016-11-15 | -$737.00M 6-K · filed 2015-10-29 | $745.00M derived: sum of 4 quarters · filed 2017-02-15 | |
| 2015-06-30 | $83.00M 6-K · filed 2016-08-04 | -$83.00M 6-K · filed 2015-07-30 | $73.00M 6-K · filed 2016-08-04 | -$73.00M 6-K · filed 2015-07-30 | $81.00M derived: sum of 3 quarters · filed 2017-02-15 | $52.00M derived: sum of 4 quarters · filed 2017-02-15 | |
| 2015-03-31 | -$10.00M 6-K · filed 2016-05-09 | $10.00M 6-K · filed 2015-04-30 | -$2.00M derived: sum of 2 quarters · filed 2017-02-15 | -$31.00M derived: sum of 3 quarters · filed 2017-02-15 | -$44.00M derived: sum of 4 quarters · filed 2017-02-15 | ||
| 2014-12-31 | $8.00M derived: 20-F 12 month − 6-K 9 month · filed 2017-02-15 | -$21.00M derived: sum of 2 quarters · filed 2017-02-15 | -$34.00M derived: sum of 3 quarters · filed 2017-02-15 | -$12.00M 20-F · filed 2017-02-15 | |||
| 2014-09-30 | -$29.00M 6-K · filed 2015-10-29 | -$42.00M derived: sum of 2 quarters · filed 2015-10-29 | -$20.00M 6-K · filed 2015-10-29 | -$10.00M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-06-30 | -$13.00M 6-K · filed 2015-07-30 | $9.00M 6-K · filed 2015-07-30 | $19.00M derived: sum of 3 quarters · filed 2016-02-11 | $30.00M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-03-31 | $21.00M 6-K · filed 2015-04-30 | $32.00M derived: sum of 2 quarters · filed 2016-02-11 | $43.00M derived: sum of 3 quarters · filed 2016-02-11 | $32.00M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | $11.00M derived: 20-F 12 month − 6-K 9 month · filed 2016-02-11 | $22.00M derived: sum of 2 quarters · filed 2016-02-11 | $11.00M derived: sum of 3 quarters · filed 2016-02-11 | $18.00M 20-F · filed 2016-02-11 | |||
| 2013-09-30 | $11.00M 6-K · filed 2014-10-30 | $0.00 derived: sum of 2 quarters · filed 2014-10-30 | $7.00M 6-K · filed 2014-10-30 | ||||
| 2013-06-30 | -$11.00M 6-K · filed 2014-07-31 | -$5.00M 6-K · filed 2014-07-31 | |||||
| 2013-03-31 | $6.00M 6-K · filed 2014-05-02 |